http://www.mediplacements.com/pharmacy_news-rss.xmlPharmacy News from Mediplacementsen-gbTue, 25 Feb 2014 20:26:25 GMTCopyright: (C) Mediplacements60http://www.mediplacements.com/images/feedlogo.gifhttp://www.mediplacements.com/images/feedlogo.gifEvery television or radio advert for a form of medication normally ends with a warning of "may contain side effects". This is always the risk when taking drugs to treat illnesses that there could be a chance that the body reacts in an unexpected way and therefore takes a turn for a worse. Side effects are normally caused when a drug ishttp://www.mediplacements.com/article-801692819-smart_medical_implants_could.htmlhttp://www.mediplacements.com/article-801692819-smart_medical_implants_could.htmlWed, 12 Feb 2014 00:00:00 GMTPharmacyFibromyalgia syndrome (FMS) is a condition that affects around one in 20 people around the world with the NHS estimating that around 1. 76 million in England and Wales live with the condition. It can normally cause chronic pain and fatigue with many patients experiencing difficulties sleeping, headaches, irritable bowel syndrome and musclehttp://www.mediplacements.com/article-801683658-vitamin_d_supplements_could.htmlhttp://www.mediplacements.com/article-801683658-vitamin_d_supplements_could.htmlFri, 17 Jan 2014 00:00:00 GMTPharmacyNovartis has announced a recall on a range of cough medicines that have been thought to be contaminated. The drug company is recalling thousands of bottles of Tixylix cough and cold medicines which are feared to have plastic in them. Officials at the firm explained that they have been made aware of a potential fault in the tamper seal which hashttp://www.mediplacements.com/article-801673012-novartis_issues_cough.htmlhttp://www.mediplacements.com/article-801673012-novartis_issues_cough.htmlMon, 16 Dec 2013 00:00:00 GMTPharmacyNHS services across the UK are set to fix the amount they spend on branded medication thanks to a new deal. The government and pharmaceutical companies have agreed to a new five-year contract on branded medication which will help to restrict the amount the NHS spends. The Pharmaceutical Price Regulation Scheme (PPRS) will see the health authorityhttp://www.mediplacements.com/article-801657820-nhs_agrees_5_year_branded.htmlhttp://www.mediplacements.com/article-801657820-nhs_agrees_5_year_branded.htmlWed, 06 Nov 2013 00:00:00 GMTPharmacyThe Department of Health recommends that young children between the ages of six months and five years, pregnant women and people over the age of 65 to take vitamin D supplements. However, new research by a team of scientists in New Zealand has found that these pills are not actually providing the beneficial effect on bone density which they arehttp://www.mediplacements.com/article-801648750-vitamin_d_supplements_failing.htmlhttp://www.mediplacements.com/article-801648750-vitamin_d_supplements_failing.htmlFri, 11 Oct 2013 00:00:00 GMTPharmacyA leading charity has warned that women who skip taking their medication for breast cancer could be putting their lives at risk. Breast Cancer Campaign explained that the lifesaving drug tamoxifen is administered to women who have been diagnosed with the condition and it is taken over a five-year period. However, the medication does come with sidehttp://www.mediplacements.com/article-801634183-women_urged_to_finish_breast.htmlhttp://www.mediplacements.com/article-801634183-women_urged_to_finish_breast.htmlThu, 05 Sep 2013 00:00:00 GMTPharmacyA new drug to treat people with epilepsy has been approved by a board of medical professionals in Wales. The medication, known as Fycompa, has been determined to help some people control their seizures which have a significant effect on a patient's life. The All Wales Medicines Strategy Group gave the go-ahead to the drug allowing doctors tohttp://www.mediplacements.com/article-801622724-new_epilepsy_drug_to_be_made.htmlhttp://www.mediplacements.com/article-801622724-new_epilepsy_drug_to_be_made.htmlThu, 08 Aug 2013 00:00:00 GMTPharmacyAntibiotics are one of the most commonly prescribed medication and used by millions of people all over the world. However, long-term use of these drugs can have its side effects but now researchers in the US have been looking at two new strategies that could prevent these dangerous responses. The team of scientists at the Wyss Institute forhttp://www.mediplacements.com/article-801609426-researchers_find_strategies_to.htmlhttp://www.mediplacements.com/article-801609426-researchers_find_strategies_to.htmlMon, 08 Jul 2013 00:00:00 GMTPharmacyStrathclyde University has secured over £34 million in funding for a project aimed at creating medicines that are cheaper and developed quicker. The Scottish institute is the head of an initiative which is designed to create and adapt medication at a much more efficient rate that is currently available at the moment. The university ishttp://www.mediplacements.com/article-801596897-strathclyde_university_secures.htmlhttp://www.mediplacements.com/article-801596897-strathclyde_university_secures.htmlMon, 10 Jun 2013 00:00:00 GMTPharmacyMedicines optimisation is being promoted through new guidance from the Royal Pharmaceutical Society (RPS) which is aimed at bringing down the cost of medicines waste. Those in pharmacy jobs are among the many health professionals being targeted by the report, which has set out four important principles to follow.  President of the RPS Martinhttp://www.mediplacements.com/article-801582009-new_guidance_aimed_at_reducing.htmlhttp://www.mediplacements.com/article-801582009-new_guidance_aimed_at_reducing.htmlTue, 07 May 2013 00:00:00 GMTPharmacyThe National Institute for Health and Care Excellence (NICE), has announced plans for a new method of treatment for patients with rheumatoid arthritis. Patients in certain circumstances can now be offered abatacept as a treatment. This relies on the patient suffering from a 'highly active' form of the condition, assessed at least onehttp://www.mediplacements.com/article-801577362-treatment_for_rheumatoid.htmlhttp://www.mediplacements.com/article-801577362-treatment_for_rheumatoid.htmlThu, 25 Apr 2013 00:00:00 GMTPharmacyThe North Tees & Hartlepool NHS Foundation Trust has announced that it has gone live with a new web-based pharmacy system. It is being supplied to the trust by Ascribe, a leading provider of clinical IT solutions, which has developed a system that has now become the industry standard. It will enable modern pharmacy departments to extend theirhttp://www.mediplacements.com/article-801576694-north_tees__hartlepool_nhs.htmlhttp://www.mediplacements.com/article-801576694-north_tees__hartlepool_nhs.htmlWed, 24 Apr 2013 00:00:00 GMTPharmacyA new pharmacy is to open in Weston-super-Mare, as part of an existing surgery in the town. The new facility at the Tudor Lodge Surgery in Nithsdale Road, will be run by the its parent company Patient Care Limited and will be open for 100 hours a week. According to the Weston Mercury, opening hours will be from 7am-10:30pm during the week, and ishttp://www.mediplacements.com/article-801568957-weston_surgery_to_open_an.htmlhttp://www.mediplacements.com/article-801568957-weston_surgery_to_open_an.htmlWed, 10 Apr 2013 00:00:00 GMTPharmacyWhile the long Easter weekend is a blessing for a lot of people, it can cause significant difficulties for patients requiring daily medication. This is why the NHS in Shropshire, Telford and Wreckin has encouraged people to be ready for the Bank Holiday period, which will see many pharmacies and doctor's surgeries closing. Many peoplehttp://www.mediplacements.com/article-801564413-patients_urged_to_check_meds.htmlhttp://www.mediplacements.com/article-801564413-patients_urged_to_check_meds.htmlThu, 28 Mar 2013 00:00:00 GMTPharmacyUp to 20 jobs will be created by a new pharmaceutical distribution facility which will open in Bridlington. Care Meds, which has an NHS contract to supply prescription medication around the country, was established by businessmen James Hesp and Richard Hoggart. The Bridlington Free Press reported that the facility will prepare and deliver medicinehttp://www.mediplacements.com/article-801536657-bridlington_based.htmlhttp://www.mediplacements.com/article-801536657-bridlington_based.htmlThu, 07 Feb 2013 00:00:00 GMTPharmacyCertain drugs used to treat depression could pose a small but serious risk to the heart, researchers have found. A study published in the British Medical Journal, suggests that drugs known as SSRIs, including citalopram and escitalopram, can trigger a disturbance to the rhythm of the heart. Regulators in both the UK and US have warned doctors tohttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlhttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlWed, 30 Jan 2013 00:00:00 GMTPharmacyCertain drugs used to treat depression could pose a small but serious risk to the heart, researchers have found. A study published in the British Medical Journal, suggests that drugs known as SSRIs, including citalopram and escitalopram, can trigger a disturbance to the rhythm of the heart. Regulators in both the UK and US have warned doctors tohttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlhttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlWed, 30 Jan 2013 00:00:00 GMTPharmacyCertain drugs used to treat depression could pose a small but serious risk to the heart, researchers have found. A study published in the British Medical Journal, suggests that drugs known as SSRIs, including citalopram and escitalopram, can trigger a disturbance to the rhythm of the heart. Regulators in both the UK and US have warned doctors tohttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlhttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlWed, 30 Jan 2013 00:00:00 GMTPharmacyCertain drugs used to treat depression could pose a small but serious risk to the heart, researchers have found. A study published in the British Medical Journal, suggests that drugs known as SSRIs, including citalopram and escitalopram, can trigger a disturbance to the rhythm of the heart. Regulators in both the UK and US have warned doctors tohttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlhttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlWed, 30 Jan 2013 00:00:00 GMTPharmacyCertain drugs used to treat depression could pose a small but serious risk to the heart, researchers have found. A study published in the British Medical Journal, suggests that drugs known as SSRIs, including citalopram and escitalopram, can trigger a disturbance to the rhythm of the heart. Regulators in both the UK and US have warned doctors tohttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlhttp://www.mediplacements.com/article-801531752-anti_depressants_could_pose.htmlWed, 30 Jan 2013 00:00:00 GMTPharmacy